Drugs / Polyenylphosphatidylcholine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00211848 | Jun 2000 → Dec 2005 | hepatitis C virus infection | Icahn School of Medicine at Mount Sinai | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Polyenylphosphatidylcholine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00211848 ↗ |
| Route | Oral | “the PPC (5 chewable tablets of 0.9 gm each per day) or corresponding placebo” NCT00211848 ↗ |